collection
MENU ▼
Read by QxMD icon Read
search

Intranasal

shared collection
13 papers 0 to 25 followers
https://www.readbyqxmd.com/read/8243872/intranasal-glucagon-treatment-relieves-hypoglycaemia-in-children-with-type-1-insulin-dependent-diabetes-mellitus
#1
RANDOMIZED CONTROLLED TRIAL
E Stenninger, J Aman
The aim of the present study was to compare intra-nasal glucagon with subcutaneous glucagon as a treatment of insulin-induced hypoglycaemia in 11 children, 7-12 years old, with Type 1 (insulin-dependent) diabetes mellitus. Hypoglycaemia (1.6 +/- 0.1 vs 1.8 +/- 0.2 mmol/l) was induced twice in each child by continuous insulin and variable glucose infusions. One milligram of intranasal glucagon or 0.5 mg of subcutaneous glucagon was given in a randomized order. At 15 min after the administrations of either intranasal or subcutaneous glucagon, the blood glucose concentration increased by 1...
October 1993: Diabetologia
https://www.readbyqxmd.com/read/2676430/intranasal-glucagon-as-remedy-for-hypoglycemia-studies-in-healthy-subjects-and-type-i-diabetic-patients
#2
COMPARATIVE STUDY
A E Pontiroli, A Calderara, E Pajetta, M Alberetto, G Pozza
Intranasal glucagon can raise blood glucose levels in healthy subjects. The aims of this study were to 1) compare the hyperglycemic effect of intranasal and intramuscular glucagon in healthy subjects and type I (insulin-dependent) diabetes patients during euglycemic conditions and 2) test the efficacy of intranasal and intramuscular glucagon in counteracting hypoglycemic episodes in insulin-treated diabetic patients. Intranasal glucagon raised blood glucose levels in both healthy subjects and type I diabetic patients, the effect of intramuscular glucagon being similar for the first 30 min and higher thereafter...
October 1989: Diabetes Care
https://www.readbyqxmd.com/read/25385946/intranasal-glucagon-a-promising-approach-for-treatment-of-severe-hypoglycemia
#3
REVIEW
Antonio E Pontiroli
Prevention of diabetic complications is mainly obtained through optimal control of blood glucose levels. With hypoglycemic drugs like beta-cell stimulating drugs and especially insulin, the limit to treatment is represented by hypoglycemia, a life-threatening occurrence that is dangerous itself and can induce fear of other episodes. Glucagon, injected subcutaneously (SC) or intramuscularly (IM), is the treatment of choice for severe hypoglycemia outside of the hospital setting. However, due to practical aspects such as preparation of solutions for administration and injection by untrained persons, there are obstacles to its routine use...
January 2015: Journal of Diabetes Science and Technology
https://www.readbyqxmd.com/read/22971130/successful-administration-of-intranasal-glucagon-in-the-out-of-hospital-environment
#4
REVIEW
Ted Sibley, Ryan Jacobsen, Joseph Salomone
We present a case of successful prehospital treatment of hypoglycemia with intranasal (IN) glucagon. Episodes of hypoglycemia can be of varying severity and often requires quick reversal to prevent alteration in mental status or hypoglycemic coma. Glucagon has been shown to be as effective as glucose for the treatment of hypoglycemia. The inability to obtain intravenous (IV) access often impairs delivery of this peptide and is therefore frequently given via the intramuscular (IM) route. Intranasal administration of glucagon has been shown to be as effective as the IV route and may be used for rapid correction of hypoglycemic episodes where IV access is difficult or unavailable and IM administration is undesirable...
January 2013: Prehospital Emergency Care
https://www.readbyqxmd.com/read/25447557/the-pichfork-pain-in-children-fentanyl-or-ketamine-trial-a-randomized-controlled-trial-comparing-intranasal-ketamine-and-fentanyl-for-the-relief-of-moderate-to-severe-pain-in-children-with-limb-injuries
#5
RANDOMIZED CONTROLLED TRIAL
Andis Graudins, Robert Meek, Dianna Egerton-Warburton, Ed Oakley, Robert Seith
STUDY OBJECTIVE: We compare the analgesic effectiveness of intranasal fentanyl and ketamine in children. METHODS: This was a double-blind, randomized, controlled trial comparing fentanyl at 1.5 μg/kg with ketamine at 1 mg/kg in children aged 3 to 13 years and weighing less than 50 kg, with isolated limb injury and pain of more than 6 of 10 at triage. The sample size was 40 in each arm. Subjects were coadministered oral ibuprofen at 10 mg/kg. The primary outcome was median pain rating reduction at 30 minutes...
March 2015: Annals of Emergency Medicine
https://www.readbyqxmd.com/read/25095322/a-comparative-evaluation-of-intranasal-dexmedetomidine-midazolam-and-ketamine-for-their-sedative-and-analgesic-properties-a-triple-blind-randomized-study
#6
RANDOMIZED CONTROLLED TRIAL
M Natarajan Surendar, R Kumar Pandey, A Kumar Saksena, R Kumar, G Chandra
OBJECTIVES: To evaluate and compare the efficacy and safety of Intranasal (IN) Dexmedetomidine, Midazolam and Ketamine in producing moderate sedation among uncooperative pediatric dental patients. STUDY DESIGN: This randomized triple blind comparative study comprises of eighty four ASA grade I children of both sexes aged 4-14 years, who were uncooperative and could not be managed by conventional behavior management techniques. All the children were randomized to receive one of the four drug groups Dexmedetomidine 1 microg/ kg (D1), 1...
2014: Journal of Clinical Pediatric Dentistry
https://www.readbyqxmd.com/read/24712757/sub-dissociative-dose-intranasal-ketamine-for-moderate-to-severe-pain-in-adult-emergency-department-patients
#7
Fiona Yeaman, Robert Meek, Diana Egerton-Warburton, Pamela Rosengarten, Andis Graudins
BACKGROUND: There are currently no studies assessing effectiveness of sub-dissociative intranasal (IN) ketamine as the initial analgesic for adult patients in the ED. OBJECTIVE: The study aims to examine the effectiveness of sub-dissociative IN ketamine as a primary analgesic agent for adult patients in the ED. METHOD: This is a prospective, observational study of adult ED patients presenting with severe pain (≥6 on 11-point scale at triage)...
June 2014: Emergency Medicine Australasia: EMA
https://www.readbyqxmd.com/read/24118506/intranasal-sufentanil-ketamine-analgesia-in-children
#8
Bettina N Nielsen, Susanne M Friis, Janne Rømsing, Kjeld Schmiegelow, Brian J Anderson, Nerea Ferreirós, Sandra Labocha, Steen W Henneberg
BACKGROUND: The management of procedural pain in children ranges from physical restraint to pharmacological interventions. Pediatric formulations that permit accurate dosing, are accepted by children and a have a rapid onset of analgesia are lacking. OBJECTIVES: To investigate a pediatric formulation of intranasal sufentanil 0.5 mcg·kg(-1) and ketamine 0.5 mg·kg(-1) for procedural pain and to characterize the pharmacokinetic (PK) profile. METHODS: Fifty children (≥10 kg) scheduled for a painful procedure were included in this prospective nonrandomized open-label clinical trial...
February 2014: Paediatric Anaesthesia
https://www.readbyqxmd.com/read/23842536/the-pichfork-pain-inchildren-fentanyl-or-ketamine-trial-comparing-the-efficacy-of-intranasal-ketamine-and-fentanyl-in-the-relief-of-moderate-to-severe-pain-in-children-with-limb-injuries-study-protocol-for-a-randomized-controlled-trial
#9
RANDOMIZED CONTROLLED TRIAL
Andis Graudins, Robert Meek, Diana Egerton-Warburton, Robert Seith, Trentham Furness, Rose Chapman
BACKGROUND: The effectiveness of intranasal (IN) fentanyl as an analgesic for painful pediatric limb injuries in the Emergency Department (ED) has been reported previously. However, efficacy of IN ketamine in sub-dissociative doses is not well studied in the ED setting. A non-blinded pilot study undertaken by this study group suggested that IN ketamine showed similar analgesic effectiveness to that reported with IN fentanyl in similar non-blinded studies. The aim of this randomized, controlled, equivalence trial is to compare the analgesic effect of sub-dissociative dose IN ketamine with IN fentanyl for children with isolated musculoskeletal limb injuries...
2013: Trials
https://www.readbyqxmd.com/read/23560967/sub-dissociative-dose-intranasal-ketamine-for-limb-injury-pain-in-children-in-the-emergency-department-a-pilot-study
#10
Fiona Yeaman, Ed Oakley, Robert Meek, Andis Graudins
OBJECTIVE: The present study aims to conduct a pilot study examining the effectiveness of intranasal (IN) ketamine as an analgesic for children in the ED. METHODS: The present study used an observational study on a convenience sample of paediatric ED patients aged 3-13 years, with moderate to severe (≥6/10) pain from isolated limb injury. IN ketamine was administered at enrolment, with a supplementary dose after 15 min, if required. Primary outcome was change in median pain rating at 30 min...
April 2013: Emergency Medicine Australasia: EMA
https://www.readbyqxmd.com/read/22858745/intranasal-ketamine-for-procedural-sedation-in-pediatric-laceration-repair-a-preliminary-report
#11
RANDOMIZED CONTROLLED TRIAL
Daniel S Tsze, Dale W Steele, Jason T Machan, Fatemeh Akhlaghi, James G Linakis
OBJECTIVE: The objective of this study was to compare the efficacy of 3 doses of intranasal ketamine (INK) for sedation of children from 1 to 7 years old requiring laceration repair. METHODS: This was a randomized, prospective, double-blind trial of children requiring sedation for laceration repair. Patients with simple lacerations were randomized by age to receive 3, 6, or 9 mg/kg INK. Adequacy and efficacy of sedation were measured with the Ramsay sedation score and the Observational Scale of Behavioral Distress-Revised...
August 2012: Pediatric Emergency Care
https://www.readbyqxmd.com/read/21292791/case-report-prehospital-use-of-intranasal-ketamine-for-paediatric-burn-injury
#12
C Reid, R Hatton, P Middleton
In this study, the administration of an intravenous ketamine formulation to the nasal mucosa of a paediatric burn victim is described in the prehospital environment. Effective analgesia was achieved without the need for vascular or osseous access. Intranasal ketamine has been previously described for chronic pain and anaesthetic premedication. This case highlights its potential as an option for prehospital analgesia.
April 2011: Emergency Medicine Journal: EMJ
https://www.readbyqxmd.com/read/8443849/nasal-ketamine-for-paediatric-premedication
#13
RANDOMIZED CONTROLLED TRIAL
N Weksler, L Ovadia, G Muati, A Stav
Ketamine in a dose of 6 mg.kg-1 was nasally administered in 86 healthy children (ASA I and II), aged from two to five years undergoing elective general, urological or plastic surgery, 20 to 40 min before the scheduled surgery time. These children were compared with 62 others, also aged from two to five years, in whom promethazine and meperidine, 1 mg.kg-1 of each, were injected im. Sedation was started as excellent in 48 and as adequate in 19 children in the ketamine group, compared with nine and 12 respectively in Group 2 (P < 0...
February 1993: Canadian Journal of Anaesthesia, Journal Canadien D'anesthésie
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"